Health
SK Bioscience embarks on clinical test of COVID-19 vaccine candidate NBP2001 – Aju Business Daily
[Courtesy of SK Bioscience]SEOUL — SK Bioscience, a cooperation partner for South Koreas state project to develop COVID-19 vaccines, will immediately embark on…
[Courtesy of SK Bioscience]
SEOUL — SK Bioscience, a cooperation partner for South Korea’s state project to develop COVID-19 vaccines, will immediately embark on the first phase of clinical trials to evaluate the safety and immunogenicity of its vaccine candidate called NBP2001. The first test will be conducted on healthy adults at a state-run hospital.The Ministry of Food and Drug Safety said that SK Bioscience has been allowed to carry out clinical trials of NBP2001, a recombinant vaccine manufactured…
-
Noosa News18 hours agoWhy buying a home in this surprise suburb could save you $400,000
-
Noosa News17 hours agoUncertainty still surrounds government pay deals with police, teachers, and nurses and midwives
-
Business16 hours agoBell Potter names cheap ASX dividend shares to buy now
-
General9 hours agoPM lauds Ukraine support as eyes turn to Trump meeting